Recent China-Israel Business Headlines
15 May 2018 - ReWalk received first tranche investment from Timwell. As previously announced, ReWalk will receive $20 million from Timwell Corporation Limited as part of a broad strategic agreement to fund ReWalk’s overall development worldwide and to establish ReWalk’s presence in the Chinese market. The company announced the first tranche has been received. Full article
11 May 2018 - Kitov Announces Commercialization Agreement for China. Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV) announced they have signed a definitive license and commercialization agreement with Hebei Changshan Biochemical Pharmaceutical for exclusive rights to import, manufacture and distribute its lead drug candidate, Consensi™, in China. Full article
11 May 2018 - Allium Medical wins Chinese marketing urological stent nod. The share price of Allium Medical Ltd. (TASE: ALMD) rose 12.5% earlier this week following an announcement that the company had obtained marketing approval for its urological stent in China. Under the terms of a previously signed distribution agreement, a Chinese company will now order NIS 88 million worth of products from Allium Medical over eight years (NIS 11 million a year). Full article
>> View all Headlines
In the Spotlight this Week
Featured Article :: China's investment restrictions: The pendulum swings back
We co-wrote this article with Tehila Levi-Lati, China head at ZAG-S&W, on China’s investment restrictions. As is often the case, it's not all gloom and doom! It's just a case of looking back to the beginning of the story.
Free China-Israel Deals Weekly Newsletter
Our China-Israel news digest, delivered to your inbox every Wednesday. Topics include deals, government initiatives and trade news.